World's Best Scientists 2026 revealed!
Florian Lordick

Florian Lordick

D-Index & Metrics

Medicine

D-Index
101
Citations
54878
World Ranking
7812
National Ranking
443

Overview

Florian Lordick is affiliated with Leipzig University in Germany and has contributed extensively to the field of medicine, with a focus on oncology and gastrointestinal cancers. Their research encompasses multiple subfields including pulmonary and respiratory medicine, surgery, gastroenterology, and radiology, nuclear medicine, and imaging.

The scientist's work centers on key topics such as gastric cancer management and outcomes, esophageal cancer research and treatment, colorectal cancer treatments and studies, gastrointestinal tumor research and treatment, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, and metastasis and carcinoma case studies.

Several notable recent papers authored or co-authored by Florian Lordick include:

  • Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2022, Annals of Oncology
  • Gastric cancer, 2020, The Lancet

Frequent co-authors collaborating with Florian Lordick include:

  • Ines Gockel, with 39 joint publications
  • Eric Van Cutsem, with 28 joint publications
  • Kohei Shitara, with 26 joint publications
  • Sylvie Lorenzen, with 25 joint publications
  • Jaffer A. Ajani, with 22 joint publications

Publication venues where Florian Lordick has published frequently include:

  • Annals of Oncology, with 38 publications
  • Journal of Clinical Oncology, with 27 publications
  • ESMO Open, with 13 publications
  • Journal of Cancer Research and Clinical Oncology, with 13 publications
  • Die Onkologie, with 13 publications

The main field of study for Florian Lordick is medicine, with a record of 709 associated publications. Subfields with the highest publication counts include pulmonary and respiratory medicine (224), oncology (172), surgery (119), gastroenterology (39), and radiology, nuclear medicine, and imaging (36).

Best Publications

  • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

    Yung Jue Bang;Eric Van Cutsem;Andrea Feyereislova;Hyun C. Chung

  • Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

    Marc Peeters;Timothy Jay Price;Andrés Cervantes;Alberto F. Sobrero

  • Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

    Gunnar Folprecht;Thomas Gruenberger;Wolf O Bechstein;Hans-Rudolf Raab

  • Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

    Florian Lordick;Yoon Koo Kang;Hyun Cheol Chung;Pamela Salman

  • PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

    Florian Lordick;Katja Ott;Bernd-Joachim Krause;Wolfgang A Weber

  • Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    F. Lordick;C. Mariette;K. Haustermans;Radka Obermannová

  • Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

    Christoph Schuhmacher;Stephan Gretschel;Florian Lordick;Peter Reichardt

  • Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

    Takashi Kojima;Manish A Shah;Kei Muro;Eric Francois

  • Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.

    Hong Yang;Hui Liu;Yuping Chen;Chengchu Zhu

  • Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment

    Hinrich A. Wieder;Björn L.D.M. Brücher;Frank Zimmermann;Karen Becker

  • Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

    Katja Ott;Wolfgang A. Weber;Florian Lordick;Karen Becker

  • Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study.

    Manish A. Shah;Takashi Kojima;Daniel Hochhauser;Peter Enzinger

  • A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

    M S Aapro;S M Grunberg;G M Manikhas;G Olivares

  • Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.

    Katja Ott;Ulrich Fink;Karen Becker;Alexander Stahl

  • ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

    Jens Hoeppner;Florian Lordick;Thomas Brunner;Torben Glatz

  • Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial.

    Manish A. Shah;Yung Jue Bang;Florian Lordick;Maria Alsina

  • Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC)

    E. Van Cutsem;Y. Kang;H. Chung;L. Shen

  • Multicenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal Cancer

    Claus Rödel;Torsten Liersch;Robert Michael Hermann;Dirk Arnold

  • Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

    S. Lorenzen;T. Schuster;R. Porschen;S.-E. Al-Batran

  • [German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer"]

    M. Moehler;Se-E. Al-Batran;T. Andus;M. Anthuber

Frequent Co-Authors

Christian Peschel
Christian Peschel Technical University of Munich
Markus Schwaiger
Markus Schwaiger Technical University of Munich
Ken Herrmann
Ken Herrmann German Cancer Research Center
Michel Ducreux
Michel Ducreux Institut Gustave Roussy
Heinz Höfler
Heinz Höfler Technical University of Munich
J. R. Siewert
J. R. Siewert University of Freiburg
Andrés Cervantes
Andrés Cervantes University of Valencia
Anja Mehnert
Anja Mehnert Leipzig University
Volker Heinemann
Volker Heinemann Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA offers a variety of online educational pathways beyond the traditional medical degree. Specialized programs can prepare students for advanced practice, healthcare management, or allied health roles, often with added flexibility and affordability.

For those aiming for high-level nursing careers, the best online dnp programs allow registered nurses to earn the Doctor of Nursing Practice, equipping them for leadership roles in patient care. Pharmacists can advance their expertise with pharmacy school online options, which provide rigorous training in pharmaceutical sciences and clinical practice.

Beyond clinical roles, the healthcare industry also relies on professionals skilled in data and administration. Earning a health information management degree online prepares graduates to manage critical patient data and health informatics systems. Meanwhile, certification programs, such as medical billing and coding certification online, open doors to vital support positions in healthcare without committing to a multi-year degree.

These diverse online degrees and certifications create multiple entry points and career advancement opportunities within the healthcare sector.

Best Scientists Citing Florian Lordick

Trending Scientists

Recently Published Articles